← Eichor
Study identifier: NCT04209127 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis

Condition: Adenomyosis  ·  Sponsor: Karolinska Institutet

PhaseNA
Planned participants70
Who can joinFemale, 30 Years to 55 Years
Healthy volunteersNo

About this study

Single blinded randomized controlled study of symptom improvement after uterine artery embolization (UAE) versus ultrasound guided percutaneous/transvaginal microwave ablation, evaluated by validated questionnaires. Adenomyosis is a benign condition causing pain and bleeding disorders in many women. Hysterectomy has historically been the golden standard for treatment as well as (postoperatively) diagnosis of the disease. In accordance with refined diagnostic tools such as ultrasound and/or MRI, minimally invasive treatments for adenomyosis are being explored. We plan to compare two minimally invasive techniques: embolization of the uterine artery (a commonly used procedure) and microwave ablation of adenomyotic tissue (previously only in clinical use in China).

This description comes directly from the study's public registry record.

Talk to the study team

Klara Hasselrot, MD PhD  ·  +46812358927  ·  klara.hasselrot@sll.se

Always discuss trial participation with your own doctor first.

Locations (1)

Danderyd HospitalStockholm, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04209127